Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
5.746B
Cash
927.1M
Avg Qtr Burn
-25.69M
Short % of Float
6.50%
Insider Ownership
4.84%
Institutional Own.
-
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GSBR-1290 (GLP-1R agonists) Details Type 2 diabetes, Obesity | Phase 2b Initiation | |
ANPA-0073 (APJ agonist) Details Pulmonary arterial hypertension, Idiopathic pulmonary fibrosis | Phase 1 Update | |
LTSE-2578 Details Idiopathic pulmonary fibrosis | Phase 1 Update |